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While this paper is to a large degree targeted for those not familiar with mass spectrometry,
[for an overview of mass spectrometry, a number of excellent websites are available, including
http://base-peak.wiley.com/links/Resources/Educational_Resources/], the primary focus is
on the importance of mass spectrometry in ultimately protecting public health and minimizing
risks of chemical exposure. Its other audience is those who practice in this specialized field.
Should this subject not interest you, by reading this article you can discover among other
things, why elevator rides can be important for your career and for your discipline. Why
acetaminophen is used for brown tree snakes, or lipid-lowering drugs for pigeons. (J Am Soc
Mass Spectrom 2001, 12, 1067–1076) © 2001 American Society for Mass Spectrometry
This paper weaves a multi-dimensioned perspec-tive of mass spectrometry as a career against thebackdrop of mass spectrometry’s key role in the
past and future of environmental chemistry. Along the
way, some insights are offered for better focusing the
spotlight on the discipline of mass spectrometry.
A Foundation for Environmental Science—Mass
Spectrometry
Historically fundamental to our understanding of envi-
ronmental processes and chemical pollution is mass
spectrometry. This branch of analytical chemistry is the
workhorse which supplies much of the definitive data
to environmental scientists and engineers for identify-
ing the molecular compositions, and ultimately the
structures, of chemicals. This is not to ignore the com-
plementary and critical roles played by the adjunct
practices of sample enrichment (e.g., to lower method
detection limits via any of various means of selective
extraction) and analyte separation (e.g., to lessen con-
taminant interferences via the myriad forms of chroma-
tography and electrophoresis).
While the power of mass spectrometry has long been
highly visible to the practicing environmental chemist,
it borders on continued obscurity to the lay public and
most non-chemists. Even though mass spectrometry
has played a long, historic and largely invisible role in
establishing or undergirding our existing knowledge
about environmental processes and pollution, what
recognition it does enjoy is usually relegated to that of
a tool. It is usually the relevance or significance of the
knowledge acquired from the application of the tool
that has ultimate meaning to the public and science at
large, not how the knowledge was acquired.
Communicating Science—Mass Spectrometry and
the Risk Paradigm
Protecting human and ecological health from chemical
hazards is rooted in assessing and managing/control-
ling chemical risks, a process requiring data from many
aspects of the risk paradigm. Comprising this paradigm
are a series of inter-related steps or activities, such as
identifying sources, establishing environmental occur-
rence, elucidating fate and transport, verifying expo-
sure or effects (e.g., bio-markers), and developing reme-
diation/control technologies. Mass spectrometry plays
a critical, direct role in all of them, except the actual step
of assessing risk (Figure 1). Mass spectrometry is essen-
tial to obtaining data required for establishing environ-
mental source/origin, occurrence (identities and con-
centrations), fate and transport (including that for all
associated transformation products), exposure (includ-
ing measurement of biomarkers), effects (including
receptor interactions and metabolites), and finally, mea-
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suring the effectiveness of mitigation, remediation, and
engineered treatment measures and technologies.
Often absent in the practicing scientist’s time-con-
suming quest to advance our understanding of the
chemical world is a concerted effort to explain to
scientists who do not rely on mass spectrometry and to
the lay public the importance of the tool, its unique
abilities, and what it can do. An imperative in the
continued health of a scientific discipline is the market-
ing of its worth and ensuring that it has a measurable
impact or outcome—one valued by society. Histori-
cally, the value of environmental chemistry has focused
on establishing a fundamental understanding of long-
existing environmental issues and principles—pollut-
ant identification, fate and transport, exposure, and
many others. A re-focus on elucidating emerging issues
(proactive versus reactive science) can improve the
visibility of mass spectrometry. This paper discusses the
ever-topical subject of communicating science, in part
by using as an example the recent, still-developing topic
of pharmaceuticals as environmental contaminants.
While mass spectrometry is an immensely powerful
tool, like many sophisticated analytical techniques, its
numerous incarnations can bewilder the non-specialist.
In the final analysis, whether a researcher is extending
the capabilities of mass spectrometry as an analytical
tool for others to use, or whether it is being used as part
of the analytical arsenal to solve chemical mysteries, it is
imperative to keep in mind that it is merely a tool, and
in general tools rarely interest the public or garner
accolades outside their disciplines of incubation and
birth. Rather, it is the outcomes from the applications of
tools that capture the public’s eye. This is the main
impetus behind the federal government’s implementa-
tion of a planning system, The Government Perfor-
mance and Results Act (GPRA) of 1993, that provides
the mandate to Federal agencies to account for program
results through the integration of strategic planning,
budgeting, and performance measurement, with an
emphasis on outcomes (e.g., impacts) as opposed to
outputs (e.g., publications, patents, citations) [for a
perspective on GPRA with respect to science, see
http://www.nsf.gov/sbe/srs/ostp/assess/nstcafsf.htm/,
http://www.nsf.gov/od/gpra/] (Figure 2). While
GPRA’s origins derive from the private sector’s contin-
ued emphasis on performance improvement over the
last decade or so, its implementation can be emulated
by the science community at large.
If we accept that one of the ultimate missions of
environmental science as that of educating the public at
large, then it is incumbent on us all to strive to commu-
nicate the significance of our work—its impact, rele-
vance, or outcome—in a way that connects with the lay
public and deepens and enriches the perspective with
which they view the world. While this ability has rarely
been a strong aspect in the training of scientists, we can
each reach out in our own way to increase the overall
knowledge of the public. With an increased public
understanding of the complexities of the biophysico-
chemical interactions of chemicals, humans, and macro-
and micro-biota, the public can eventually gain a
heightened appreciation for the reality of the uncertain-
ties scientists continually face in developing definitive
conclusions and the importance of the analytical reper-
toire of the analytical chemist, especially the central role
of mass spectrometry. In the absence of a larger under-
standing and active communication of outcomes and
impacts, our work simply ends with an undefined,
hanging ellipsis . . .
If one accepts the fact that an important objective of
environmental science is to sharpen society’s focus on
personal responsibility and accountability for the con-
sequences of our actions, activities, and behaviors, then
mass spectrometry plays an immensely important but
necessarily low-profile role. It is hoped that this greater
public awareness of environmental issues would lead to
better control over the fate of our environment and
health.
The canyon separating the general public’s knowl-
Figure 2. Relative importance of outputs and outcomes as cod-
ified in the Government Performance and Results Act.
Figure 1. Mass spectrometry and the risk paradigm. Central role
of mass spectrometry in elucidating the risks associated with
environmental pollutants.
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edge of science from reality is often highlighted and
debated. Responsibility for this chasm is relegated to
various parties. A telling national survey of general
science knowledge was completed in March 2001. The
survey was conducted by the California Academy of
Sciences and Harris Interactive Polling [http://
www.calacademy.org/geninfo/newsroom/releases/
survey_results.htm]. The results of three questions were
particularly illuminating. (1) 53% of adults did not
know that the earth revolves around sun, (2) 48% had
no sense of the percentage of earth’s surface covered by
water, and (3) 42% did not know whether humans
co-existed with dinosaurs. These results highlight a
profound national knowledge gap at a time when a
democratic discussion of many, complex technical is-
sues is critical for our future. Meaningful public con-
sensus and informed decisions can only result from a
sufficient and widely held knowledge base. Further-
more, the poll indicated that the public (65%) trusts
scientists (not educators) most to convey needed infor-
mation about the natural world; the public (95%) is also
extremely interested in learning about the environment.
Clearly the responsibility rests with scientists to better
communicate the meaning, significance, and impact of
their work, in clearly articulated terms.
An Example—PPCPs
One of the critical roles historically played by mass
spectrometry is elucidating the identities of previously
unknown or unrecognized (mystery) pollutants, often
referred to as emerging pollutants; such detective work
is sometimes called environmental forensics. This paper
focuses on the still-developing outcome of one such
application of mass spectrometry, the elucidation of the
widespread environmental occurrence of low-levels of
numerous chemical members from the many classes of
pharmaceuticals and personal care products (PPCPs),
many of which are highly bioactive. The role of mass
spectrometry in this emerging issue is clearly evident in
the published studies that have identified PPCPs in a
range of environmental samples (see studies captured
in a comprehensive review [1]).
PPCPs are a diverse group of chemicals, used inter-
nally or externally with the bodies of humans and
domestic animals and plants, comprising all drugs
available by prescription or over-the-counter; including
the new genre of biologics, diagnostic agents (e.g., X-ray
contrast media), nutraceuticals (bioactive food supple-
ments such as huperzine A), and other consumer chem-
icals, such as fragrances (e.g., synthetic musks) and
sun-screen agents (e.g., methylbenzylidene camphor);
also included are excipients (so-called inert ingredients
used in PPCP manufacturing and formulation). Many
PPCPs are highly bioactive, most are polar, many are
optically active, and all, when present in the environ-
ment, usually occur at no more than trace concentra-
tions. The confluence of these factors presents a number
of additional analytical challenges.
While the release to the environment of PPCPs from
manufacturing processes is controlled by regulatory
means in the United States, but not in all countries [2],
PPCPs largely owe their origins in the environment to
their worldwide, universal, frequent, and highly dis-
persed but aggregate and cumulative usage by multi-
tudes of individuals and by agriculture; continuing and
escalating introduction to the marketplace of new ar-
rays of drugs with new modes of action is expected to
be fueled by advances in genomics and proteomics.
Occurrence of PPCPs in the environment mirrors the
intimate, inseparable, and immediate connection be-
tween the actions and activities of individuals and their
environment.
In addition to the more widely publicized occurrence
of antimicrobials and steroidal hormones, over 50 indi-
vidual PPCPs or metabolites from more than 10 broad
classes of therapeutic agents or personal care products
had been identified as of 1999 [1] in environmental
samples, mainly in sewage, surface, and ground waters,
and much less frequently in drinking waters. It is
important to note that although a number of represen-
tatives from small subsets of therapeutic classes have
been identified in the environment, numerous members
of most classes have yet to be searched. Many of these
unreported drugs are among the most widely pre-
scribed medications in the U.S., and little data exists to
lead to a conclusion that they do not occur. In addition
to the table of PPCPs with documented environmental
occurrence provided in [1], a complementary list of
those that have no occurrence data is provided in [3].
The latter list can serve as a guide for those scientists
who are interested in expanding the existing environ-
mental occurrence database.
Portions of the parent form of most ingested drugs
are excreted in varying amounts, sometimes in undis-
solved states because of absorption/metabolic protec-
tion by excipients, primarily via feces and urine. Other
portions sometimes yield metabolites possessing bioac-
tivity. Still other portions are excreted as conjugates.
Freely excreted drugs and derivatives can escape deg-
radation in municipal sewage treatment facilities (re-
moval efficiency is a function of the drug’s structure
and treatment technology employed); the conjugates
can be hydrolyzed back to the free parent drug. Unde-
graded molecules are then discharged to receiving
surface waters or find their way to groundwaters (e.g.,
via leaching or purposeful recharge). Extensive over-
views of the topic have been presented in review
articles [1, 3–7], in an upcoming ACS book [8], and on a
U.S. EPA website devoted to the topic [9].
Mass spectrometry provided the underlying capabil-
ity for the scientists who have elucidated this emerging
topic largely over the course of the last 10 years. As
such, this is just one of countless examples of how mass
spectrometry has played a leading (albeit largely invis-
ible) role in the communication of major environmental
knowledge and lessons to the public over the last 30
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years. Its continuing future role for other currently
unrecognized chemical risks will surely continue.
As an historical aside, probably the first report of a
prescription drug in the environment (sewage treat-
ment effluent) was made over 20 years ago (see sum-
mary in [1]) and was that of clofibric acid, the active
metabolite from the high-volume, high-dosage lipid
regulators clofibrate, etofibrate, and theofibrate. While
this data was acquired over 20 years ago and was
pointing to the possibility that the continual, daily
introduction of substantial quantities of drugs and
bioactive metabolites from the combined excreta of
end-users to and from sewage treatment plants into
receiving waters could result in sustained environmen-
tal concentrations of PPCPs, the larger phenomenon
was not really recognized until the 1990s, with the
advent of in-depth studies targeted for PPCPs. Clofibric
acid is one of the more persistent PPCPs that reaches
concentrations (e.g., sub-ppb) in open waters on par
with those of many conventional pollutants, such as the
persistent organic pollutants (POPs). Clofibric acid pre-
sents an interesting historical aside. As a phenoxyal-
kanoic acid, the achiral clofibric acid (2-[4-chlorophe-
noxy]-2-methylpropionic acid) is a structural isomer of
the enantiomeric herbicide mecoprop (2-[4-chloro-2-
methylphenoxy]-propanoic acid). Both of these com-
pounds can co-occur in waters. While the methyl esters
of both compounds can be separated by gas chroma-
tography, their electron ionization (EI) mass spectra
share molecular ions of m/z 228 as well as a major
fragment at m/z 169. Other than these two ions, how-
ever, the use of EI mass fragmentation (Figure 3) affords
distinctive patterns, largely because of the chlorophenol
moiety, that can be compared with those of standards.
Mass spectrometry has played a key, but behind-the-
scenes, role in sorting out environmental forensics
problems such as this one for many years.
Critical Role of Environmental Chemistry
The National Research Council (as requested by the
National Science Foundation) synthesized the broad
expertise from across the many disciplines embodied in
environmental science to offer its judgment on what the
most significant environmental research challenges of
the next generation are, based on their potential to
provide a scientific breakthrough of practical impor-
tance to mankind, if given major new funding.
Of the eight grand challenges identified in the NRC’s
report Grand Challenges in Environmental Sciences [10],
two require concerted input from those involved with
pollutant identification: (1) Hydrologic forecasting for
predicting changes in freshwater resources as a result,
in part, of chemical contamination; a concern, for exam-
ple, regarding PPCPs, and (2) reinventing the use of
materials. The impetus driving the second is “. . . new
compounds and other substances are constantly being
incorporated into modern technology and hence into
the environment, with insufficient thought being given
to the implications of these actions. All of these issues
assume added importance in urban areas, which con-
centrate flows of resources, generation of residues, and
environmental impacts within spatially constrained ar-
eas. From a policy standpoint, reliable predictive mod-
els of material cycles could be invaluable in guiding
decisions about . . . topics relating to human-environ-
ment interactions . . . . This grand challenge centrally en-
compasses questions about societal-level consumption
patterns, since consumption is the primary force driv-
ing human perturbations of material cycles.”
Emerging Chemical Risks
One of the signature science responsibilities of the U.S.
EPA’s Office of Research and Development (ORD) as
well as for other environmental science institutions
throughout the world is to pioneer and nurture new
programs for identifying, evaluating, and developing
the requisite science for minimizing existing, or pre-
venting future, exposure risks from previously unrec-
ognized and unexpected chemicals. By using various
approaches to discovery, “futuring” [e.g., see http://
www.geocities.com/CapitolHill/Senate/4787/index.
html/ and http://www.epa.gov/ordinter/futures/],
and fast failure analysis, a major objective is to mini-
mize the time required to transfer new science to other
parts of the EPA, to other government agencies and
research institutions, and to the public. This type of
science can eventually guide society away from a reac-
Figure 3. EI mass spectra of the methyl esters of two ubiquitous
and persistent bioactive phenoxyalkanoic acid pollutants. Both are
structural isomers, and structures of the free acids are displayed;
the antilipidemic drug metabolite clofibric acid (upper spectrum;
2-[4-chlorophenoxy]-2-methylpropionic acid) and the herbicide
mecoprop (lower spectrum; 2-[4-chloro-2-methylphenoxy]-pro-
panoic acid). Spectra adapted from Buser et al. Environ. Sci.
Technol. 1998, 32 (1), 188–192.
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tionary mode of being forced to deal with entrenched
environmental problems, and instead orient it more
towards proactive, preventative science.
The term emerging only reflects one aspect of the
overall issue surrounding the need to minimize or
prevent exposure risks. Because of this, the term can
misrepresent and obscure the overall issue. Those risks
emanating from chemical pollution can be classified
into four main categories: (1) Growing/developing, (2)
hidden/latent, (3) emerging, and (4) future. Clearly, the
term emerging only accounts for one of four possible
categories of previously unrecognized or unanticipated
exposure risks, but this term is nonetheless used to
encompass all four categories. The following presents a
discussion of these four areas of concern with respect to
chemical pollution and how to view them under one
umbrella.
Importance of Chemical Exposure in Health
As the more important determinant of overall health
(i.e., as measured at least by certain cancers), the expo-
sure environment rather than genetics is becoming
more firmly established (e.g., note one of the most
thorough studies to date using birth twins [11]).
While genetics obviously sets the stage (genotype)
for health, the chemical environment to which an or-
ganism is exposed defines and molds the actual char-
acter (phenotype) in which an organism manifests itself.
The chemical sea in which an organism develops,
matures, and subsists comprises substances essential to
life (nutrients) as well as those adverse to life, both
naturally occurring xenobiotics and anthropogenic pol-
lutants. The latter includes substances purposefully
designed and synthesized, sometimes with the intent to
adversely affect organisms, (e.g., pesticides, antimicro-
bials) and those that are inadvertent and sometimes
hidden by-products of manufacture, consumption, me-
tabolism, and environmental transformation. This par-
tial accounting of the potential chemical-exposure uni-
verse is immense, possibly comprising millions of
substances.
Those substances subject to EPA’s historical regu-
latory framework possibly represent but a small
subset, largely a result of expediency and necessity.
The majority of the quantities of individual chemicals
released to the environment by permitted dischargers
are not regulated; few chemicals released to the
environment by consumers are regulated. Just be-
cause these uncontrolled pollutants are not classified
as priority pollutants does not mean that they do not
pose risks. This is the major impetus behind the
emergence, primarily in Europe, of the Precautionary
Principle [12].
Need for Holistic Exposure Assessments
The exposure environment to which environmental
toxicologists have traditionally focused their attention
is limited to the conventional pollutants that comprise
the various lists of regulated pollutants, also called
criteria, priority, or legacy pollutants. These are primar-
ily the high-volume industrial chemicals and manufac-
turing by-products, nutrients, and those substances
specifically designed to kill pests. It is important to note
that the feature distinguishing these several hundred
chemicals is the fact that they are produced and con-
sumed in the highest quantities amongst all chemicals.
Unfortunately, these chemicals comprise but a very
small portion of the universe of xenobiotics to which
organisms can and do suffer exposure. While the
numbers of regulated pollutants worldwide total
about 220,000 as of 2001 [see http://www.cas.org/
CASFILES/chemlist.html/], only a small portion of
these are routinely monitored for occupational or envi-
ronmental purposes. In stark contrast, the numbers of
synthetic and naturally occurring xenobiotics constitut-
ing the potential exposure universe probably comprise
many hundreds of thousands; this is undoubtedly a
conservative estimate given that Chemical Abstracts
Service has registered over 15 million organic and
inorganic substances as of 2001, and over 1,800,000 of
these are readily available commercially [http://
www.cas.org/cgi-bin/regreport.pl/]. When consider-
ing the high-profile, regulated categories of chemicals,
regulators have not been able to consider the complex-
ities and ramifications of complete exposure profiles,
including the full range of bioactivity of all parent
substances and the multitudes of transformation prod-
ucts, or their exposure frequency, exposure duration
(sustained cumulative effects), or exposure complexity
(aggregate or cumulative exposure or synergism).
Given this limitation, it is critical that holistic assess-
ments of the wide range of potential environmental
pollutants be made and those pollutants with highest
health-effects potential pinpointed.
To this end, an objective of EPA ORD science is to (1)
elucidate a more rounded, expanded view of the expo-
sure universe, (2) at least be better prepared to cope
with newly identified or previously unrecognized pol-
lutants, and (3) lay the foundation for developing an
ultimate ability to foresee/predict potential chemical
pollution problems before they develop. As such, this
work relates to the unknown rather than to the better-
defined exposure world that we have come to greatly
understand over the last 40 years.
Emerging Issues and Short-Circuiting Risk
The type of work described here is often referred to as
emerging issues. The term emerging however, is highly
overused, one whose banner is frequently raised in
many fields of study, from politics and economics to
math, ecology, and epidemiology. In particular, emerg-
ing has a long-established, strong connotation associ-
ated with pathogens and infectious diseases (e.g., at the
U.S. Food and Drug Administration [FDA] and the
Centers for Disease Control and Prevention [CDC]). In
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addition, for reasons discussed below, emerging is not
the best descriptor for the work required with PPCPs or
most other previously unrecognized pollutants. Emerg-
ing is a misnomer with respect to chemical pollution
because many or most of the instances in which it is
employed deal either with issues that have existed for
some time and have eluded our attention for a variety
of reasons, or with those issues that have yet to occur.
Only a fraction of cases involve new problems that are
truly just in the process of occurring or developing—
emerging.
The Varied Dimensions of the Exposure
Continuum
Previously unrecognized, unexpected, or unanticipated
scenarios of exposure to chemicals can be pursued or
viewed from a number of different perspectives. There
are several different dimensions that can account for the
universe of potential chemical toxicants. From each of
these dimensions comes a different perspective in terms
of how the chemical universe pie or continuum is sliced.
These different perspectives often inject confusion into
discussions oriented to anticipating future risks or
uncovering existing, but previously unrecognized,
risks. Further complicating the multidimensioned view
of chemical exposure risks is the fact that the various
subsets of chemicals comprising each of these different
perspectives can overlap to various degrees; portions of
each subset can belong to others.
Previously Unrecognized Chemical Exposure Risks
Can Be Delineated Based on the Following
Dimensions
• Chemical classes (according to chemical function-
ality: chemicals of totally new structure).
• Type of use (new uses in either the industrial or
consumer realms).
• Type of effect (newly discovered but prior-exist-
ing effects or totally new receptor targets or li-
gand-receptor interactions).
• Source (new or previously unknown origins for
existing chemicals).
• Exposure (pathways that had not been anticipated,
or previously discounted as not possible).
The following now historical examples using PPCPs are
provided for each of these dimensions to clarify the
distinctions among them.
• New chemical classes: angiogenesis inhibitors.
• Type of use: sexual dysfunction (e.g., Viagra);
selective serotonin reuptake inhibitors (SSRIs).
• Type of effect: endocrine disruptors; broad-spec-
trum efflux pump inhibitors; NO regulators (e.g.,
Viagra); COX-2 inhibitors.
• Source/matrix: humanitarian assistance projects
as a source of drugs in environment from disposal;
drinking water as source of unintentional multi-
drug ingestion; drugs used for pest control. (Many
drugs have not just multiple therapeutic uses but
sometimes uses unrelated to therapy. Examples
include 4-aminopyridine, an experimental multi-
ple sclerosis drug and an avicide; warfarin, an
anticoagulant and a rat poison; triclosan, a general
biocide and gingivitis agent used in toothpaste;
azacholesterols, antilipidemic drugs and avian/
rodent reproductive inhibitors [e.g., Ornitrol]; cer-
tain antibiotics used for orchard pathogens; acet-
aminophen, an analgesic and useful for control of
brown tree snakes).
• Exposure route: ingestion of synthetic musk fra-
grances via fish; inhalation of drinking water dis-
infection by-products via showering.
Even though these distinctions of perspective make no
difference with respect to the technical design, imple-
mentation, or understanding of research in this area,
they can have a dramatic impact in the communication
of the work to non-experts. As an example, the issue of
endocrine disruption slices the pie along the effects axis,
at the same time cutting across several other axes; for
example, endocrine disrupting compounds (EDCs)
comprise substances from numerous chemical classes,
and they can have many different commercial and
consumer end uses. Among EDCs are certain drugs
(which represent a broad use class), but only a certain
small percentage of drugs are direct-acting EDCs (i.e.,
hormone receptor agonists/antagonists). Alternatively,
if one slices the universe of chemicals along the type-
of-use axis, all pharmaceuticals can be embraced in a
broad category, and while some of these are EDCs, the
remainder have a multitude of effects removed from
that of the immediate endocrine system. Each axis can
yield a slice of the chemical universe, which in turn
provides a unique view of the exposure continuum.
Terms to Categorize the Continuum of Risk
There is actually a continuum of terms, each of which
partly categorizes a portion of the work that needs to be
done with respect to addressing the world of what we
inaccurately refer to as emerging issues or emerging
science, specifically, emerging pollutants. This contin-
uum comprises
1. Long-established, widely recognized risks: These
constitute the vast majority of the U.S. EPA’s historic
business regarding chemical pollution, such as POPs,
persistent bioaccumulative toxicants (PBTs), and nu-
trients.
2. Unexpectedly growing/developing risks: Pre-exist-
ing, but already recognized low-level potential that
has now unexpectedly grown to become a newly
recognized risk (data were available to recognize the
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potential for onset of a risk but the heightened risk
developed unexpectedly).
3. Hidden, latent risks: Those previously unrecog-
nized risks that have already existed for some time
but are just becoming recognized, uncovered, or
discovered (this category includes chemicals not
known to already exist in the environment as well as
existing, unassessed chemicals of historically little
concern but which harbor unexpected/unpredicted
effects). Success controlling these risks results via
remediation and pollution prevention.
4. Emerging, nascent risks: Those that have not
previously existed and which are just beginning to
develop or emerge; this category involves new chem-
icals that never before existed as well as new uses for
old chemicals. There is a need to pay more attention
to those chemicals whose uses have little or no
regulation. Success in controlling these risks results
in early warning.
5. Future risks, currently non-existent risks: Those
that do not currently exist but which can be foreseen,
predicted, or anticipated. Success here results in
outright prevention of risk that could/would have
otherwise occurred.
If we pause to consider PPCPs in this framework (as
illustrative cases), it is clear that with the exception of
new-generation PPCPs (not previously existing), these
chemicals all fall within category 3 (previously unrec-
ognized risks) because they have undoubtedly had the
potential to occur in the environment ever since they
became commercially available (in many cases decades
ago) and within category 2, since their prevalence in the
environment is increasing as a result of increasing
consumption, expanding therapeutic targets, and in-
creasing population, among other reasons. New-gener-
ation drugs subject to the FDA approval process would
usually fall under category 5.
For the last 20–30 years, EPA’s research has gener-
ally focused on long-established risks involving the
conventional, regulated legacy pollutants, many of
which, such as the POPs, have presented intractable,
refractory problems (Category 1). Together with cate-
gories 2 and 3, these are the three main areas of
chemical pollution on which environmental protection/
regulatory bodies have traditionally focused, and out of
necessity almost exclusively in a reactive mode. All of
the other chemicals that comprise categories 2 and 3 can
be referred to as unassessed or un(der)addressed chem-
icals or non-regulated/non-conventional pollutants.
Category 4 (emerging risks) occurs only when newly
introduced chemicals or by-products enter or are cre-
ated within the environment, or when new, uncon-
trolled sources come on line. Perchlorate was somewhat
in this category as well as category 3. Many little-
discussed chemicals belong to category 3 simply be-
cause of years of neglect; a case in point being the
numerous members of dust/erosion-control agents,
substances that can be used in very large quantities.
Clearly, society’s major desire would be to focus and
succeed with category 5 so that resources that would
otherwise have to be devoted to categories 2–4 can be
minimized or eliminated. This would allow society to
get and remain ahead of the curve, to be proactive
rather than reactive, to focus on pollution prevention
rather than remediation. Progress in category 4 pro-
vides early warning, which also helps to minimize
resources that would need to be devoted to an other-
wise larger problem. Instead of focusing on identifying
emerging concerns (category 4), which is still a reactive
way of protecting health, it would be better to cast our
efforts proactively, to minimize future risk and correct
yet-to-be-identified risks, to combat future, would-be
risks. But this cannot be done until the existing risks
have been fully elucidated. Mass spectrometry will
undoubtedly continue to play a key role in this en-
deavor for years to come.
Two High-Priority Needs in Environmental
Analytical Chemistry
Two long-standing needs for enhancing our sentinel
ability to corral emerging contaminant issues are, (1)
enrichment techniques for preconcentrating from aque-
ous media not just hydrophobic compounds, but also
polar substances, and (2) automated approaches to
mass spectrometry for non-target analysis. Respective
examples include, (1) devices [13, 14] designed to collect
polar compounds from large volumes of water, and (2)
a high-resolution mass spectrometry approach [15] for
rapidly narrowing the universe of molecular composi-
tions for non-target unknowns. These needs are partic-
ularly important for extending our knowledge of PPCPs
in the environment.
. . . And Many Others
Additional avenues await advancements from newer or
better applications of mass spectrometry. Chirality is
one. The bioactivity of drugs is, not surprisingly, often
controlled by their optically active forms. Chirality
plays a very large role in the biochemistry of drugs.
While nearly all drugs derived from natural sources are
expectedly homochiral, synthetic single-enantiomer
drugs or those with specifically designed enantiomeric
ratios are only beginning to be used (Table 1). Biodeg-
radation discriminates among isomers leading to tell-
tale enrichment of one form over another. This can
potentially alter the toxicity of the residues because
chiral drug isomers can work in synergy or against each
other, (e.g., one can give adverse effects, or one can be
inactive) and used to fingerprint the weathered status of
residues. Traditionally, mass spectrometry was not be-
lieved to be useful to differentiate chirality. But its
potential for fast chiral discrimination and detection of
low enantiomeric excesses would be useful for a variety
of purposes, including the verification and tracking of
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the performance of natural attenuation for site cleanup.
Another need is for identification of protein sequencing
(peptide mapping) in proteomics, a field that holds
tremendous importance for both drug discovery, via
identification of new targets, and prediction of health
effects from environmental exposure. Mass spectro-
metry has already played a large role in elucidating
ligand binding but continued advances are needed.
Expanding Your Horizons—Seizing New
Perspectives
Now, returning to why elevator rides can be important
for your career and for your discipline, some closing
words on communicating our science.
The elevator speech. Can you explain to your captive
elevator audience (when ascending from the first to
fourth floor) not just what you do and what it involves,
but why it’s important to them? Force yourself to
initiate discussions with people who may have no clue
as to what your work is about and see if the glassy-eyed
stares end your monolog prematurely. Long-known in
the corporate community as the elevator speech, it can
be one of the most important presentations you ever
deliver. It can open doors for future opportunities, and
it can expand the horizons of all. So the next time
someone asks “. . . and what do you do?” resist the
reflexive “I’m a mass spectrometrist” or some such, and
instead say something to the effect “My laboratory
research at . . . improves the . . . of citizens by develop-
ing new aspects of chemistry which are important to
you because . . . .” This is your sound bite for the
listener to subconsciously memorize, hopefully for later
recitation to others. End your speech by asking what is
the single most important thing you could do in the
future as a scientist to help them further understand the
importance of science. For imparting more perspective,
tell your listeners what would happen if you were not
engaged in the work you do, e.g., what would happen
if mass spectrometry ceased to be practiced? Remember
that your communication is not just for your sake, but
also for the continued advancement of your field. To
successfully communicate with those in other profes-
sions, one must learn to cast ideas in the frame of
understanding used by others. As an example, the need
is rapidly growing for environmental scientists to com-
municate with the mainstream business community so
that environmental objectives and policies that are both
scientifically and economically sound can be embraced,
valued, and championed by both business and science.
The doors can open onto floors you never knew existed. Make
a habit of reading well outside your area of expertise or
interest in both technical and lay literature. New, totally
unforeseen perspectives can be gained rapidly. At con-
ferences, attend some sessions outside your specialty or
established interests. You might find that the perspec-
tives of others can help you expand your horizons.
Reciprocally, your expertise might be of critical use to
them. The lay person can unexpectedly provide per-
spectives on your work that you never contemplated, or
reinvigorate your own interests, thereby opening new
avenues of research. Conference organizers can gain
tremendous perspective by having journalists give con-
cluding remarks, to relate what they heard at the
meeting, which may surprise the participants and at-
tendees and give them a better appreciation for how
difficult effective communication can be.
Capitalize on the unexpected. Although measurement of
performance is designed to target intended or antici-
pated outcomes, sometimes unanticipated outcomes
can have significant importance. By way of example, for
the issue of PPCPs in the environment, perhaps the
major unanticipated outcome to date has been the value
of the topic in imparting knowledge of environmental
science to the lay public, including schools and the
media. The public makes a natural connection to the
topic, because it demonstrates first hand the intercon-
nectedness of humans and their environment, a connec-
tion that is immediate, intimate, and inseparable.
Marketing versus selling. Simply explaining what we
do as researchers (selling our wares) is but one dimen-
sion of successful science. More important is identifying
those societal needs to which our work can contribute
and make a difference. The extension or development of
new knowledge is only one aspect of our work; we
must be able to explain what it means, and put it to use.
This is the all-important value-added aspect of our
work. In Bruce Alberts’ 2000 President’s Address to the
National Academy of Sciences (Science and Human
Needs, [http://www.nas.edu], he addresses in part the
responsibilities of scientists with the following words:
“. . .Because political will is often short term, and mis-
Table 1. Synthesis-origin and chiral distribution of discrete drugs worldwidea
Source Achiral
Chiral
Worldwide
totalsRacemic
Single
enantiomer
Natural (or derived analog) 6 8 509 523
Synthetic 799 467 61 1327
Worldwide totals 805 475 570 1850
aAdapted from: W. Locke, The Alchemist, January 2001: http://www.chemweb.com/alchem/articles/985883680391.html.
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information about science abounds, we scientists our-
selves must become much more engaged in the every-
day life of our governments and our communities.” As
civic scientists, . . . “in the 21st century, science and
scientists will be judged on how well they help solve
local and world problems, not only on how well they
generate new knowledge. The impact of our research is
everywhere, and we must step out and make sure that
our work is understood and appropriately used by the
world. . . . We also need to be explicit about what is not
known, and be clear about the questions that science
cannot answer.”
In Donald Stokes’ Pasteur’s Quadrant [16], a model is
constructed where strictly knowledge-oriented research
(called the Bohr quadrant) lies diametrically to strictly
use-oriented research (the Edison quadrant). With in-
creasing pressure over the last decade to shift funded
research away from the Bohr quadrant (knowledge for
knowledge’s sake), in order to gain funding, newly
proposed research is often forced into the Edison quad-
rant. Many believe this breeds a dangerous vulnerabil-
ity for eroding science’s foundation upon which future
advancements can be built. A fused balance of the two
quadrants resides in the Pasteur quadrant, where a
constant communication between all stakeholders and
potentially interested parties can ensure that the pur-
sued work will result in contributing to construction of
road maps that lead to destinations of value while
giving the future the ability to sail into currently un-
contemplated, unchartered waters.
Spend time at the edges (remember, interesting chemistry
happens at interfaces). Just as many interesting environ-
mental processes, not the least of which was perhaps
the beginnings of life, occur at complex media inter-
faces, the same applies to disciplines. The perceived
value of disciplines onto themselves, i.e., studies in
isolation, is diminishing as the interconnected complex-
ities of nature and society become more evident to the
scientist and public alike. The birth of new knowledge,
insights, and ideas is clearly catalyzed in the cauldron-
like interfaces where multiple disciplines can coalesce.
This method for unleashing creativity was adopted by
Hewlett-Packard Co. in 2000 for their vast restructur-
ing, and was referred to as inventing at the intersection
by CEO Carleton Fiorina. Try to communicate, or better
yet, collaborate, with scientists in other disciplines. If
you don’t think that any linkage is possible between
mass spectrometry and social science, business, or en-
tertainment engineering, try to find out in person. Work
outside your comfort zone, expand your envelope, and
embrace what was once not there.
The fragmentation of science—loss of the bigger picture
(critical importance of knowledge mining and synthe-
sis). Where and how does your work fit into the larger
scheme? Much of the world’s published science litera-
ture is vastly underutilized and highly fragmented.
With respect to environmental aspects of PPCPs, for
example, the medical literature in particular has yet to
be effectively utilized to address ecological effects ques-
tions. While the information available in any research
field continues to grow exponentially, proportionately
less time is devoted in trying to mine and capture this
knowledge to synthesize a larger picture. (Note that
mining is used here in the sense of knowledge not data.
The latter pertains to the tool called meta-analysis, not
to general knowledge as a synthesis of ideas, concepts,
insights, perspectives, etc.) Literature is often ignored or
simply becomes lost to future investigators. The para-
doxical message is that the published literature is not as
important as new findings. Duplication of effort and
reinvention of the wheel are symptoms of the failure to
pay sufficient attention to the literature. A parallel
problem is that the larger picture remains obscure when
the literature is not critically examined, especially for
issues that cross multiple disciplines. Solutions to prob-
lems and answers to questions can be waiting to be
discovered amidst research that has already been re-
ported. But the literature is also corrupted with misin-
formation and inaccuracies, all of which must be fil-
tered out. True brilliance resides in the ability to filter
the errant from the cogent.
This problem results in part from the fact that
there is little professional reward in attempting to
distill, synthesize, and integrate what is known about
a topic. Science managers tend to value publication of
original data, even if it is incremental, and even if,
unbeknownst them, it is merely rediscovered data.
Furthermore, scientists often have little time to un-
derstand the significance, impact, or relevance of
their work because they are caught in the drive to
publish, at the expense of reading, comprehending,
distilling, synthesizing, and communicating the rele-
vance of their work.
The issue of capture and synthesis of fragmented
knowledge has been cogently discussed [17] by Profes-
sor Peter Csermely (Semmelweis University, Budapest).
Csermely argues that little attention is being paid to the
fragmentation of the world’s science literature. This is a
major reason why it is so extremely difficult for indi-
vidual scientists to have a broad-based appreciation for
the bigger picture. Csermely writes: “There is only a
limited effort to achieve the appropriate balance be-
tween the discovery of new facts and finding their
proper place and importance in the framework of
science.” This relates partly to what can be referred to as
understanding the significance, impact, or relevance of
one’s work. Csermely goes on to note that “Science
itself is not self-integrating, and there are fewer and
fewer people taking responsibility for net-making. In-
tegration (of knowledge) needs time and patience . . .
greater credit should be given to those who make
serious attempts to integrate their findings into the
whole of human knowledge.”
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